News
BSX
95.76
-0.31%
-0.30
The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price
Seeking Alpha · 4h ago
Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA
NASDAQ · 11h ago
Peter Lynch Detailed Fundamental Analysis - BSX
NASDAQ · 13h ago
Weekly Report: what happened at BSX last week (1222-1226)?
Weekly Report · 17h ago
Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside
Seeking Alpha · 1d ago
Does Boston Scientific’s Strong Run Match Its Current Valuation in 2025?
Simply Wall St · 5d ago
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
NASDAQ · 5d ago
Boston Scientific: Gangbusters Growth, And A Valuation To Match
Seeking Alpha · 5d ago
PAHC or BSX: Which Is the Better Value Stock Right Now?
NASDAQ · 5d ago
Boston Scientific’s Global Pulsed Field Ablation Trial Targets Persistent Atrial Fibrillation Growth
TipRanks · 5d ago
February 2026 Options Now Available For Boston Scientific (BSX)
NASDAQ · 5d ago
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?
NASDAQ · 5d ago
Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors?
The Motley Fool · 5d ago
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
NASDAQ · 6d ago
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens
NASDAQ · 6d ago
Should You Hold On To BSX Stock Despite Its Premium Valuation?
NASDAQ · 6d ago
Boston Scientific (BSX) Receives a Buy from Stifel Nicolaus
TipRanks · 12/23 01:15
Notable ETF Inflow Detected - IVW, CRM, BSX, PGR
NASDAQ · 12/22 16:05
Weekly Report: what happened at BSX last week (1215-1219)?
Weekly Report · 12/22 09:42
1 Safe-and-Steady Stock with Promising Prospects and 2 We Ignore
Barchart · 12/22 06:16
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.